David Dinsmoor, the local Medtronic engineer who worked on Inceptiv Medtronic researchers say a recently approved closed-loop spinal cord stimulator marks one of the company’s biggest breakthroughs in ...

Medtronic has begun enrolling patients in its clinical trial for a back pain treatment device, according to the Memphis Business Journal. The trial is for its peripheral nerve stimulation technique, ...

Medtronic said the U.S. Food and Drug Administration has approved a new spinal-cord implant that relieves chronic pain, a bid to expand into a patient population that relies heavily on medications ...

How Medtronic spinal cord stimulation therapy helped one woman reclaim her life. For more than a decade, Lynnette lived in the shadow of debilitating pain. What began as persistent discomfort in her ...

Medtronic ((MDT)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to ...

Medtronic has issued an urgent medical device correction on its SynchroMed II implantable drug infusion pumps, warning that the batteries in certain devices might suddenly fail, according to a news ...

(Reuters) - Medtronic Plc has agreed to stop manufacturing and distributing its SynchroMed implantable drug pump, U.S. regulators said on Monday, a step toward resolving allegations that the company ...

Mylan has rejected Teva’s unsolicited bid. Robert J. Coury, Mylan’s executive chairman, said Teva’s roughly $40 billion offer grossly undervalues the company and “would require Mylan’s shareholders to ...